IP Library Assignment 051769/0927
Patent Assignment
Reel/Frame 051769/0927

Assignment of Assignor's Interest

Recorded: 2020-02-10 Pages: 19
Assignor
XBIOTECH INC.
Executed: 2019-12-30
Assignee
JANSSEN BIOTECH, INC.
800/850 RIDGEVIEW DRIVE, HORSHAM, PENNSYLVANIA, 19044
Covered Properties (35)
Interleukin-1 Alpha Antibodies
Patent: 8,034,337 →
Application: 12/455,458 →
Publication: US 2009/0298096
Modulation of the Amount or Function of Pathogenic CD14+CD16+ Monocytes
Patent: 8,242,074 →
Application: 12/559,019 →
Publication: US 2010/0068212
Arthritis Treatment
Application: 13/162,705 →
Publication: US 2011/0311547
Treatment for Neoplastic Diseases
Application: 13/215,464 →
Publication: US 2012/0045444
Interleukin-1 Alpha Antibodies and Methods of Use
Patent: 8,388,969 →
Application: 13/224,913 →
Publication: US 2012/0014971
Interleukin-1 Alpha Antibodies and Methods of Use
Patent: 8,388,956 →
Application: 13/224,943 →
Publication: US 2012/0015433
Interleukin-1 Alpha Antibodies and Methods of Use
Application: 13/224,975 →
Publication: US 2012/0021512
Interleukin-1 Alpha Antibodies and Methods of Use
Application: 13/225,004 →
Publication: US 2012/0164665
Interleukin-1 Alpha Antibodies and Methods of Use
Patent: 8,962,814 →
Application: 13/225,029 →
Publication: US 2012/0015384
Treatment of Dermatological Pathologies
Application: 13/437,159 →
Publication: US 2012/0251548
Modulation of Pathogenic CD14+/CD16+ Monocytes
Patent: 8,546,331 →
Application: 13/545,166 →
Publication: US 2012/0276110
Cachexia Treatment
Patent: 9,809,649 →
Application: 13/624,004 →
Publication: US 2013/0078258
Treatment of Inflammatory Skin Disease
Patent: 9,724,409 →
Application: 13/644,976 →
Publication: US 2013/0039921
Inhibiting Cell Migration
Patent: 8,679,489 →
Application: 13/762,453 →
Publication: US 2013/0171728
Method for Killing Il-1 Alpha Expressing Cells
Patent: 8,784,817 →
Application: 13/767,292 →
Publication: US 2013/0177982
Treatment of Psychiatric Conditions
Application: 13/928,020 →
Publication: US 2013/0287788
Treatment of Diabetes
Patent: 9,545,441 →
Application: 14/030,561 →
Publication: US 2014/0086933
Treating Vascular Disease and Complications Thereof
Application: 14/044,418 →
Publication: US 2014/0099321
NUCLEIC ACIDS ENCODING A HUMAN MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO IL-1a
Patent: 8,956,831 →
Application: 14/177,892 →
Publication: US 2014/0186943
Human Antibody Specific for IL-1alpha
Patent: 9,181,338 →
Application: 14/567,072 →
Publication: US 2015/0094455
Human Antibody Specific for Interleukin-1alpha
Patent: 9,840,558 →
Application: 14/877,964 →
Publication: US 2016/0024202
Arthritis Treatment
Application: 15/235,263 →
Publication: US 2017/0002071
Treatment of Dermatological Pathologies
Patent: 9,902,769 →
Application: 15/252,477 →
Publication: US 2016/0368982
Treatment of Diabetes
Patent: 9,988,447 →
Application: 15/364,597 →
Publication: US 2017/0081403
Cachexia Treatment
Application: 15/730,218 →
Publication: US 2018/0037647
Human Antibody Specific for Interleukin-1ALPHA
Application: 15/789,774 →
Publication: US 2018/0127495
Treating Vascular Disease and Complications Thereof
Application: 15/800,407 →
Publication: US 2018/0057585
Treatment of Hidradenitis Suppurativa
Application: 15/899,864 →
Publication: US 2018/0230211
Treatment of Psychiatric Conditions
Application: 16/112,496 →
Publication: US 2018/0360960
Treatment for neoplastic diseases
Application: 16/228,060 →
Publication: US 2019/0127460
Arthritis Treatment
Application: 16/530,667 →
Publication: US 2019/0352391
Treatment of Hidradenitis Suppurativa
Application: 16/540,543 →
Publication: US 2019/0389946
Treatment of Atopic Dermatitis
Application: 62/811,238 →
Treatment of Hidradenitis Suppurativa
Application: 62/811,696 →
Antibody Formulation
Application: 62/837,942 →
Related Assignments (16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 12, 2009
From: SIMARD, JOHN
To: XBIOTECH, INC.
Reel/Frame 023091/0933 →
Assignment of Assignor's Interest Nov 18, 2009
From: SIMARD, JOHN
To: XBIOTECH, INC.
Reel/Frame 023535/0037 →
Assignment of Assignor's Interest Jun 30, 2011
From: SIMARD, JOHN
To: XBIOTECH, INC.
Reel/Frame 026527/0259 →
Assignment of Assignor's Interest Sep 6, 2011
From: SIMARD, JOHN
To: XBIOTECH, INC.
Reel/Frame 026857/0558 →
Assignment of Assignor's Interest Sep 6, 2011
From: SIMARD, JOHN
To: XBIOTECH, INC.
Reel/Frame 026857/0486 →
Assignment of Assignor's Interest Sep 9, 2011
From: SIMARD, JOHN
To: XBIOTECH, INC.
Reel/Frame 026878/0015 →
Assignment of Assignor's Interest May 15, 2012
From: SIMARD, JOHN
To: XBIOTECH, INC.
Reel/Frame 028208/0536 →
Assignment of Assignor's Interest Jul 10, 2012
From: SIMARD, JOHN
To: XBIOTECH, INC.
Reel/Frame 028520/0434 →
Assignment of Assignor's Interest Oct 10, 2012
From: SIMARD, JOHN
To: XBIOTECH, INC.
Reel/Frame 029104/0173 →
Assignment of Assignor's Interest Oct 10, 2012
From: SIMARD, JOHN
To: XBIOTECH, INC.
Reel/Frame 029103/0906 →
Assignment of Assignor's Interest Feb 8, 2013
From: SIMARD, JOHN
To: XBIOTECH, INC.
Reel/Frame 029779/0058 →
Assignment of Assignor's Interest Feb 14, 2013
From: SIMARD, JOHN
To: XBIOTECH, INC.
Reel/Frame 029816/0158 →
Assignment of Assignor's Interest Apr 17, 2014
From: SIMARD, JOHN
To: XBIOTECH INC
Reel/Frame 032698/0997 →
Assignment of Assignor's Interest Jun 18, 2014
From: SIMARD, JOHN
To: XBIOTECH, INC.
Reel/Frame 033129/0058 →
Assignment of Assignor's Interest Dec 11, 2014
From: SIMARD, JOHN
To: XBIOTECH, INC.
Reel/Frame 034480/0743 →
Assignment of Assignor's Interest Jan 4, 2024
From: JANSSEN BIOTECH, INC.
To: XBIOTECH INC.
Reel/Frame 066022/0815 →